Editorial
doi: 10.1016/j.pain.2008.03.005.
Epub 2008 Apr 1.
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors
Affiliations
- PMID: 18384959
- PMCID: PMC2453778
- DOI: 10.1016/j.pain.2008.03.005
Item in Clipboard
Editorial
Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors
Pain.
2008 Jun.
No abstract available
Comment in
-
Determining long-term efficacy for treatment of chronic pain in fibromyalgia patients.Pain. 2008 Aug 31;138(2):473-474. doi: 10.1016/j.pain.2008.07.017. Epub 2008 Aug 5. Pain. 2008. PMID: 18684565 No abstract available.
-
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.Pain. 2008 Oct 15;139(2):477-479. doi: 10.1016/j.pain.2008.07.026. Epub 2008 Sep 13. Pain. 2008. PMID: 18790568 No abstract available.
Comment on
-
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.Pain. 2008 Jun;136(3):432-444. doi: 10.1016/j.pain.2008.02.024. Epub 2008 Apr 18. Pain. 2008. PMID: 18395345 Clinical Trial.
-
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.Pain. 2008 Jun;136(3):419-431. doi: 10.1016/j.pain.2008.02.027. Epub 2008 Apr 8. Pain. 2008. PMID: 18400400 Clinical Trial.
Similar articles
-
Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.Pain. 2008 Oct 15;139(2):477-479. doi: 10.1016/j.pain.2008.07.026. Epub 2008 Sep 13. Pain. 2008. PMID: 18790568 No abstract available.
-
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.Pain. 2008 Jun;136(3):432-444. doi: 10.1016/j.pain.2008.02.024. Epub 2008 Apr 18. Pain. 2008. PMID: 18395345 Clinical Trial.
-
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.Pain. 2008 Jun;136(3):419-431. doi: 10.1016/j.pain.2008.02.027. Epub 2008 Apr 8. Pain. 2008. PMID: 18400400 Clinical Trial.
-
Current progress in the pharmacological therapy of fibromyalgia.Expert Opin Investig Drugs. 2009 Oct;18(10):1479-93. doi: 10.1517/13543780903203771. Expert Opin Investig Drugs. 2009. PMID: 19732029 Review.
-
Pharmacotherapy of fibromyalgia.Am J Health Syst Pharm. 2011 Jul 15;68(14):1307-19. doi: 10.2146/ajhp100322. Am J Health Syst Pharm. 2011. PMID: 21719591 Review.
Cited by
-
A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain.Pain Res Manag. 2011 Sep-Oct;16(5):337-51. doi: 10.1155/2011/465281. Pain Res Manag. 2011. PMID: 22059206 Free PMC article. Review.
-
New treatment options in the management of fibromyalgia: role of pregabalin.Neuropsychiatr Dis Treat. 2008 Dec;4(6):1193-201. doi: 10.2147/ndt.s3257. Neuropsychiatr Dis Treat. 2008. PMID: 19337459 Free PMC article.
-
Pregabalin: a review of its use in fibromyalgia.Drugs. 2008;68(15):2205-23. doi: 10.2165/00003495-200868150-00009. Drugs. 2008. PMID: 18840008 Review.
-
Importance of Measuring Placebo Factors in Complex Clinical Trials.Pain. 2008 Aug 31;138(2):474. doi: 10.1016/j.pain.2008.07.016. Epub 2008 Aug 5. Pain. 2008. PMID: 19724636 Free PMC article. No abstract available.
-
The placebo response: relationship to outcomes in trials of postherpetic neuralgia.Clin Drug Investig. 2010;30(11):739-48. doi: 10.2165/11584300-000000000-00000. Clin Drug Investig. 2010. PMID: 20818836 Review.
References
-
- Arnold LM, Goldenberg DL, Stanford SB, Lalonde J, Sandhu HS, Keck PE, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336–1344. - PubMed
-
- Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5–15. - PubMed
-
- Bausell RB, Lao L, Bergman S, Lee WL, Berman BM. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval Health Prof. 2005;28:9–26. - PubMed
-
- Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum. 1994;37:32–40. - PubMed
-
- Crofford LJ, Mease PJ, Simpson SL, Young JP, Martin SA, Haig GM, Sharma U. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-months, double-blind, placebo-controlled trial with pregabalin. Pain. 2008 (please add volume and pages) - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
